[Modification of serum lipids and glucose tolerance by sequential Ovosiston and Minisiston].
The influence of two kinds of contraceptive pills, a sequential one and a combined one (Sequenz-Ovosiston and Minisiston), on serum lipoproteins and carbohydrate metabolism was investigated in 32 young patients who got these drugs for the first time during a period of 12 months. There were no pathological values of cholesterol, high density proteins, low density proteins, triglycerides or oral glucose tolerance test during and after the treatment. The authors summarized, that neither Sequenz-Ovosiston nor Minisiston increase the risk of atherosclerosis and of diabetes in young healthy women.
D000293:Adolescent; D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D002715:Chlormadinone Acetate / Q000009:adverse effects*; D002784:Cholesterol / Q000097:blood; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects*; D003279:Contraceptives, Oral, Sequential / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004997:Ethinyl Estradiol / Q000009:adverse effects*; D019304:Ethinyl Estradiol-Norgestrel Combination; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D008055:Lipids / Q000097:blood*; D008074:Lipoproteins / Q000097:blood; D008656:Mestranol / Q000009:adverse effects*; D009644:Norgestrel / Q000009:adverse effects*
D001786:Blood Glucose; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D003279:Contraceptives, Oral, Sequential; D008055:Lipids; D008074:Lipoproteins; D002715:Chlormadinone Acetate; D009644:Norgestrel; D004997:Ethinyl Estradiol; D019304:Ethinyl Estradiol-Norgestrel Combination; C002785:Ovosiston; D002784:Cholesterol; D008656:Mestranol
Die Beeinflussung der Serumlipide und der Glucosetoleranz durch Sequenz-Ovosiston und Minisiston.